BRCA2 and cancer: Michalak and Kang (2018) highlighted a unique and likely pathogenic divergence of the BRCA2 in Homo neanderthalensis relative to other primates, including modern humans, raising a question about cancer susceptibility in the archaic species that were replaced by modern humans 40,000 years ago [39].